Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
06:08pm, Wednesday, 05'th Jun 2024
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advise
The Schall Law Firm Announces A Probe Into Allegations Against Zoetis Inc. (NYSE:ZTS) And Encourages Investors With Losses To Reach Out
01:00pm, Wednesday, 05'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
USNA vs. ZTS: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 05'th Jun 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the b
Zoetis Releases 2023 Sustainability Report to Share Progress in Building a Better Future for Communities, Animals and the Planet
09:00am, Wednesday, 05'th Jun 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis Inc. today published its 2023 Sustainability Report “Advancing Sustainability in Animal Health for a Better Future,” to highlight t
The 7 Best Dividend Stocks to Buy in June 2024
07:30am, Wednesday, 05'th Jun 2024
You may have heard the pithy investing mantra to “sell in May and go away.” Because stocks tend to underperform during the summer months, the idea is to sit them out and wait for better opportunit
The Schall Law Firm Declares an Examination into Accusations Against Zoetis Inc. and Urges Investors with Losses to Communicate
02:30pm, Tuesday, 04'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
My Top 15 High Growth Dividend Stocks For June 2024
11:46am, Monday, 03'rd Jun 2024
The SPDR S&P 500 ETF Trust had a 5.06% gain in May, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares, +3.33%. The top 15 dividend growth stocks for June 2024 offer an average divid
LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
12:00pm, Saturday, 01'st Jun 2024
NEW YORK, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or the "Company") (NYSE:ZTS). Such investors are advised to contact Dan
LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
07:20pm, Thursday, 30'th May 2024
NEW YORK , May 30, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised to contact Dan
LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoet
Beat the Dow Jones With This Cash-Gushing Dividend Stock
08:15am, Thursday, 30'th May 2024
Zoetis is the clear leader in the global animal healthcare industry. Its newest osteoarthritis medications are seeing early success.
